Tirzepatide (2023788-19-2)
Product Summary
Tirzepatide (CAS: 2023788-19-2) is a first-in-class GLP-1/GIP dual agonist white powder. It offers a paradigm shift in managing Type 2 Diabetes and Obesity, enabling significant improvements in blood sugar control and weight. For R&D use only.
Product Custom Attributes
Product Description
Tirzepatide is a groundbreaking, first-in-class GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) dual receptor agonist, designed to address two of the most prevalent and interconnected metabolic health challenges: Type 2 Diabetes Mellitus and Chronic Obesity.
Tirzepatide is more than a treatment—it's a paradigm shift in managing metabolic health, empowering patients to achieve significant, sustainable improvements in their blood sugar control, weight, and overall quality of life.
*The product under patent is only for R&D use.
Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.
